Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda

INTRODUCTION: Preventive therapy is essential for reducing tuberculosis (TB) burden among people living with HIV (PLWH) in high‐burden settings. Short‐course preventive therapy regimens, such as three‐month weekly rifapentine and isoniazid (3HP) and one‐month daily rifapentine and isoniazid (1HP), m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Olivia, Jo, Youngji, Pennington, Jeff, Johnson, Karl, Chaisson, Richard E, Churchyard, Gavin, Dowdy, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569168/
https://www.ncbi.nlm.nih.gov/pubmed/33073520
http://dx.doi.org/10.1002/jia2.25623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569168/
https://www.ncbi.nlm.nih.gov/pubmed/33073520
http://dx.doi.org/10.1002/jia2.25623

Ejemplares similares